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Induction of inducible nitric oxide synthase in mononuclear phagocytes by IFN-γ and
innate tumor necrosis factor (TNF) provide the basis for an effective immune response to
the intracellular parasite Leishmania (L.) major. In previous experiments, we observed a
fatal visceral form of leishmaniasis in L. major-infected C57BL/6 TNF−/− mice. To further
delineate the protective function of TNF and its receptor requirements, we comparatively
assessed L. major-infected C57BL/6 mice that were either deficient for membrane
and soluble TNF (Tnf−/−), for soluble TNF alone (memTnf/), or the TNF receptors
type 1 (Tnfr1−/−) or type 2 (Tnfr2−/−). We detected locally and systemically increased
levels of the cytokine IFN-γ in the absence of the TNF-TNFR1-signaling pathway. An
analysis of transcription factors and cytokines revealed that activated Tnf−/− CD4+ T
cells displayed a highly active Th1 phenotype with a strong usage of the T cell receptor
Vβ5.1/2. From these data we conclude that the fatal outcome of L. major infection in
Tnf−/− mice does not result from a skewed or deficient Th1 differentiation.
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INTRODUCTION
Cutaneous leishmaniasis is caused by different species of the protozoan parasite genus Leishmania
(L.) such as the “old world” species of Leishmania major (Reithinger et al., 2007; Schonian et al.,
2008), which are transferred by the bite of a sand fly (Sacks and Perkins, 1985). In the case of a
L. major infection, the clinical manifestation is limited to a local skin lesion that heals without
further treatment. However, depending on the host immune response and the parasite species and
strain, chronic, non-healing skin ulcers and widespread tissue destruction or even systemic parasite
dissemination have also been observed (Reithinger et al., 2007).
The immune response to L. major in the skin and draining LNs has been analyzed extensively
using high- or low-dose mouse infection models (Sacks and Noben-Trauth, 2002; Bogdan, 2008;
Liese et al., 2008), but is still only partly understood. In genetically self-healing C57BL/6 mice a
protective immune response against L. major occurs that is characterized by an initial boost of
interferon (IFN)-α/β (Diefenbach et al., 1998), the rapid induction of IL-12 (Scharton-Kersten
et al., 1995), the production of IFN-γ by NK cells and the differentiation of Th1 cells (Liese et al.,
2007; Lykens et al., 2010; Prajeeth et al., 2011). IFN-γ drives macrophages to upregulate the enzyme
inducible nitric oxide synthase (iNOS, NOS2; Ding et al., 1998) to produce large amounts of the
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leishmanicidal effector molecule nitric oxide (NO) from
L-arginine (Deng et al., 1993), a process synergistically supported
by tumor necrosis factor (TNF; Ding et al., 1998). Synthesis
of NO is essential for the resolution of L. major infections
in vivo (Liew et al., 1990; Stenger et al., 1994, 1996; Diefenbach
et al., 1998; Prajeeth et al., 2011). This well established chain of
immunological events in the resistant C57BL/6 mouse contrasts
with the immune response to L. major in the genetically
susceptible (i.e., non-healing) BALB/c mouse which shows an
early and sustained IL-4 expression that results in a progressive
infection (Sacks and Noben-Trauth, 2002). The observed
dichotomy in the cytokine response led to the development of
the Th1–Th2 model of T cell differentiation, which interprets
genetic differences of cytokine expression as causal for the
disparate clinical outcomes observed in experimental cutaneous
Leishmaniasis (Mosmann and Coffman, 1989). However, more
recent work has demonstrated that this classical model is too
simplistic, as newly characterized T cell populations (e.g.,
Th17 cells, regulatory T cells) (Alexander and Brombacher,
2012), early chemokine expression (Roebrock et al., 2014) and
differential wound healing mechanisms (Baldwin et al., 2007)
need to be taken into account when discussing genetic and
immunological reasons for susceptibility to L. major. In addition,
in TNF-deficient mice L. major-specific T cells displayed strong
in vitro IFN-γ expression, but in vivo failed to achieve control
of L. major as TNF−/− mice succumbed to the infection within
6–7 weeks (Wilhelm et al., 2001). These and other results, which
contradicted the classical Th1/Th2 dichotomy (Belosevic et al.,
1989; Anderson et al., 2005), suggested that the presence of
IFN-γ is necessary, but not sufficient for the control of L. major
in vivo.
To further address the role of TNF for the innate and adaptive
response to L. major and to reconcile previous discrepant results
obtained with TNF- or TNF-receptor-deficient mouse strains of
different genetic origins (Vieira et al., 1996; Nashleanas et al.,
1998; Chakour et al., 2003), we infected mice deficient for
membrane and soluble TNF (Tnf−/−), for soluble TNF alone
(memTnf/), for TNF receptor type 1 (Tnfr1−/−), or type 2
(Tnfr2−/−) on a pure C57BL/6 background to comprehensively
assess the course of leishmaniasis. Subsequently, we compared
the expression of IFN-γ and the underlying T cell response in Wt
and Tnf−/− mice to analyze and quantify the adaptive immune
response in the absence of TNF in more detail.
MATERIALS AND METHODS
Mice
The gene-targeted C57BL/6 mouse strains deficient for both
soluble and membrane TNF (Tnf−/−) or for soluble TNF only
(memTnf/) were generated on a genetically pure C57BL/6
(Wt) background (Körner et al., 1997; Ruuls et al., 2001). The
Tnfr1−/− (Jackson stock number: 003242) and Tnfr2−/− mice
(Jackson stock number: 002620) were obtained from Jackson
Laboratories and had been backcrossed more than 10 times or
had been established on a C57BL/6 background, respectively
(Peschon et al., 1998). The screening procedure followed the
protocols published previously (Körner et al., 1997; Peschon
et al., 1998). All animals were kept under specific pathogen-free
conditions at the Animal Research Facilities of the University
of Tasmania, Australia, the Comparative Genomics Centre,
James Cook University, Australia, and the Institute for Clinical
Microbiology, Immunology and Hygiene at the University
Hospital of Erlangen, Germany. All experiments followed
protocols approved by the animal ethics committees of James
CookUniversity, Townsville, the University of Tasmania, Hobart,
Tasmania and the Government of Mittelfranken, Germany. Mice
of an age of 8–12 weeks were used in all experiments.
Parasites and Infection
The virulent L. major isolate MHOM/IL/81/FE/BNI (Solbach
et al., 1986; Stenger et al., 1996) was maintained through
serial passage in BALB/c mice in vivo and cultured in vitro
in Novy-Nicolle-MacNeal blood agar slants in RPMI1640
medium supplemented with 10% new born calf serum,
penicillin/streptomycin, non-essential amino acids and 10 mM
HEPES, all supplied by Invitrogen Life Technologies (Mount
Waverly, Australia). For infection, stationary phase L. major
promastigotes were used between passage 2 and 6 and 3 × 106
parasites were injected in a volume of 40μl into one hind footpad.
The infection site was monitored daily and the increase in lesion
size was determined weekly by measuring the footpad thickness
with a metric caliper (Kroeplin Schnelltaster, Schluechtern,
Germany). The percentage of increase in footpad thickness
was determined by the formula (thickness of infected footpad
minus thickness of non-infected footpad/mean thickness of non-
infected footpad) × 100. The parasite burden (per gram of tissue)
was determined at day 28 post infection (p. i.) using a limiting
dilution method and L-Calc software version 1.1 (Stem Cell
Technologies, www.Stemcell.com) which performs a generalized
Pearson Chi-squared test (Wilhelm et al., 2001).
Flow Cytometry
Draining popliteal (p) lymph nodes (LN) or footpad lesions
were incubated with collagenase D (1 mg/ml, Roche Products
Australia, Brisbane, QLD, Australia) and DNAse 1 (100 U/ml,
Sigma–Aldrich) for 30 min at 37◦C and disrupted between
frosted glass slides yielding single cell suspensions. Cells were
filtered through 60μm nylon meshes or 40 μm cell strainers (BD
Biosciences, Sydney, NSW, Australia) to remove tissue debris.
Prior to FACS staining the cells were blocked with either anti-
CD16/32 antibody (clone 2.4G2, eBioscience, San Diego, CA,
USA) or 10% rat serum (IMVS, Adelaide, SA, Australia). Cells
were stained with rat-anti-mouse antibodies specific for B220
(RA3-6B2, Pacific Blue, or APC-Cy7), CD4 (RM4-5, PerCP-
Cy5.5, or Pacific Blue), CD8 (53–6.7, Pacific Blue), CD25 (PC61,
APC; 7D4, FITC), CD44 (IM7, PeCy7), CD62L (MEL-14, APC),
GITR (DTA-1, PeCY7), Vß4 TCR (KT4, PE), Vß5.1/5.2 TCR
(MR9-4, FITC) CD3ε (145-2C11, PE-Cy7), IL-17 (TC11-18H10,
PE), IL-4 (11B11, PE), IFN-γ (XMG1.2, Alexa Fluor-488) and
with Armenian hamster-anti-mouse antibodies specific for TCR
β-chain (H57-597, APC or biotin/Streptavidin Pacific Orange).
Multicolour staining of single cells for surface antigens was
performed as published (Wilhelm et al., 2001). Data were
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acquired using a Cyan ADP (Beckman Coulter, Fullerton, CA,
USA). Analyses were performed using FlowJo R© version 8.86
(Tree Star Inc.).
Cell Isolation
CD4+ T cells were isolated from draining LN using antibody
labeled magnetic beads (Miltenyi Biotec Australia, Sydney, NSW,
Australia). Briefly, the LN were disrupted between frosted glass
slides yielding single cell suspensions. The cells were washed with
PBS/0.1% BSA and incubated with anti-CD4 beads (Miltenyi
Biotec) for 15 min on ice. After labeling, all CD4+ cells (naïve
as well as activated) were isolated using a standard lymphocyte
protocol on a fully automated autoMacs Pro Separator (Miltenyi
Biotec) which was provided by the manufacturer.
Cytokine Analysis
Intracellular cytokine staining was performed on antigen-
stimulated T cells. Cells that included CD4+ T cells and
antigen-presenting cells were re-stimulated in 96 well plates
(Sarstedt Australia, Mawson Lakes, SA, Australia) at a density
of 5 × 105 cells using freeze-thawed L. major antigen (MOI
equivalent= three) for 72 h in RPMI1640medium supplemented
with 10% new born calf serum, penicillin/streptomycin, non-
essential amino acids, and 10 mM HEPES, all supplied by
Invitrogen Life Technologies (Mount Waverly, Australia). For
the last 6 h of culture the cells were kept in the presence
of PMA (20 ng/ml)/ionomycin (1 μg/ml) and Golgi-StopTM
(BD Biosciences, 4 μg/ml). Subsequently, the cells were stained
for surface antigens, fixed, permeabilised using FoxP3-FixPerm
buffer (Biolegend, Perth, Australia) and stained for IFN-γ, IL-4,
and IL-17 following the manufacturers’ instructions.
Serumwas collected from experimental animals weekly during
the course of infection. Cytokine levels were measured in mouse
serum and tissue culture supernatants using mouse inflammation
cytokine bead array (CBA, BD Biosciences). CBA were acquired
on the ARIA II and FCS 2.0 files were analyzed using FCAPArray
(Soft Flow Inc, Burnsville, MN, USA).
Real-time RT-PCR was performed with total RNA extracted
from footpad lesions using Trizol (Invitrogen). Following
DNase treatment of RNA (using RQ1 RNase free DNase;
Promega, Sydney Australia) cDNA synthesis was performed
with Superscript III reverse transcriptase (Invitrogen). Gene
expression analysis was performed using SYBR-green-ER qPCR
kit (Invitrogen) or Brilliant II SYBR-green (Agilent Technologies,
Integrated Sciences, Willoughby, NSW, Australia), run on a
Corbett Rotor Gene 6000 (Qiagen, Doncaster, Australia) and
analyzed using REST 2009 gene expression software (Qiagen)
to determine relative expression of genes. PCR primers were
designed using Vector NTI (Invitrogen): β-actin-forward: AAT
CCT GTG GCA TCC ATG AAA C, β-actin-reverse: CGC AGC
TCA GTA ACA GTC CG; GAPDH- forward: GTG AAG GTC
GGT GTG AAC GG, GAPDH-reverse: ATG TTA GTG GGG
TCT CGC TCC; Gata3-forward: GAG GTG GAC GTA CTT
TTT AAC AT, Gata3-reverse: GGC ATA CCT GGC TCC CGT;
Hprt-forward: GTT GGT TAC AGG CCA GAC TTT GTT G,
Hprt-reverse: GAG GGT AGG CTG GCC TAT AGG CT; Il-10-
forward: GGTTGCCAAGCCTTATCGGA, Il-10-reverse: ACC
TGC TCC ACT GCC TTG CT; Il-17A-forward: TCT GTG TCT
CTG ATG CTG TTT GC, Il17A-reverse: ACG GTT GAG GTA
GTC TGA GGG C; Ifn-γ-forward: AGA GCC AGA TTA TCT
CTTTCTAC, Ifn-γ-reverse: CTTTTT TCGCCTTGCTGCTG;
Rorγt-forward: CCG CTG AGA GGG CTT CAC, Rorγt-reverse:
TGC AGG AGT AGG CCA CAT TAC A; Tbx21-forward: CAA
CAACCCCTTTGCCAAAG,Tbx21-reverse: TCCCCAAGCA
AGT TGA CAGT.
Statistics
Statistical analysis was performed using a non-parametric
Mann Whitney U-test, a Kruskall–Wallis with Dunn’s multiple
comparison test or a two-way ANOVA test with Bonferroni
correction to test for multiple hypotheses. Mean values (±SEM)
are shown. Analysis was performed using GraphPad Prism 5.0
for MacIntosh (GraphPad Software, San Diego, CA, USA, www.
graphpad.com). Each experimental group was compared to Wt
controls. Statistical p values of p < 0.05 were considered to be
significant (with ∗p < 0.05 and ∗∗p < 0.01, respectively).
RESULTS
Clinical Course of L. major Infection in
the Absence of TNF or its Receptors
The published clinical outcomes of L. major infection in
Tnfr1−/− and Tnfr2−/− mice (Vieira et al., 1996; Nashleanas
et al., 1998) were significantly different from the infection of
Tnf−/− mice (Wilhelm et al., 2001). It has been shown earlier
using bone marrow reconstitution that changes in the lymphoid
organs due to the absence of TNF signaling only have a minimal
influence on the clinical outcome of the infection (Wilhelm
et al., 2001). Therefore, this could reflect the use of different
L. major strains (Ritter et al., 2004) or the genetic heterogeneity
of the mouse strains. Therefore, we infected Tnf−/−, Tnfr1−/−,
Tnfr2−/−, and memTnf/ strains (Körner et al., 1997; Peschon
et al., 1998; Ruuls et al., 2001) with the pathogenic L. major
isolate BNI and monitored the course of disease (Figure 1).
In accordance with previously described results obtained with
a different strain of L. major (Allenbach et al., 2008), infected
memTNF/ mice, which express the membrane form but lack
the ability to release soluble TNF, and Wt control mice showed
a comparable course of infection (Figure 1) and were able to
control the infection. In contrast, L. major-infected Tnf−/−,
Tnfr1−/−, and Tnfr2−/− mice all developed similar, large skin
lesions strikingly different from the Wt control mice. At day 56
all control mice had resolved their lesions, whereas infected Tnf-
and Tnfr1-deficient mice had to be euthanized in accordance
with animal ethics considerations because the animals developed
signs of systemic distress. L. major-infected Tnfr2-deficient mice
developed large lesions, which were comparable in size to those
in TNF or TNFR1 mice, but ultimately controlled the infection
(Figure 1 and data not shown). The wildtype controls [C57BL/6,
shown as B6.WT (Figure 1) and BALB/c (data not shown)]
exhibited the expected symptoms with B6.Wt controlling the
infection whereas BALB/c succumbing to a progressive infection.
From these data we conclude that TNF and TNFR1 are both
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FIGURE 1 | Course of infection in Tnf- and Tnfr-negative mouse
strains. The lesion sizes of Tnf−/− (n = 34), memTnf/ (n = 5), Tnfr1− /−
(n = 27), and Tnfr2−/− (n = 27) mice, which had been infected
subcutaneously with Leishmania major in one hind footpad were determined
and compared to Wt (n = 36). The data are presented as percent increase in
footpad lesion size. The combined results of four experiments are shown as
mean (±SEM) and the number of animals stated above is the maximal
number at the beginning of the experiment. The differences in clinical outcome
were combined for analysis using a two-way ANOVA with Bonferroni
correction to test for multiple hypotheses.
essential for controlling an infection with L. major, whereas
TNFR2 only plays a contributory role. Furthermore, membrane
TNF alone is sufficient to convey protection.
Induction of IFN-γ Response in Tnf−/−
Mice During L. major Infection
The cytokine milieu is essential for induction of a leishmanicidal
response in macrophages and for the establishment of protective
immunity. To determine the impact of a TNF or TNF receptor
deficiency on the development of the adaptive immune response,
we first infected Wt, Tnf−/− and BALB/c mice with L. major
and analyzed CD4+ T cells from popliteal draining lymph nodes
(pLN) for their expression of IL-4, IFN-γ, IL-17, and IL-10. We
observed a relatively early, strong IL-4 expression in all mouse
strains on day 7 p. i., which had largely disappeared on day 21
p. i. (Figure 2A). IFN-γ was present in all three genotypes with
a significantly elevated expression in TNF−/− (see Figure 2B),
while another pro-inflammatory cytokine, IL-17, was hardly
detectable in CD4+ T cells of any strain at the analyzed time-
points (Figure 2A). The expression of IL-10 was determined after
7, 21, and 28 days and was very similar to IL-4 expression with a
strong presence at day 7 p. i., and fast down-regulation thereafter
(Figure 2A). Both IL-4 and IL-10 were co-expressed with IFN-γ
in 1 – 2% of all cells (Figure 2A). This finding is likely to reflect a
random heterogeneity during the differentiation of Th1 and Th2
cells at the beginning of the adaptive immune response (Morris
et al., 1992), as the IL-4-, IL-10-, and IFN-γ-co-expressing cells
were only detectable at day 7 p. i.
A quantification of the IFN-γ expression in the serum of
all genotypes at days 7, 14, 21, 28, and 35 p. i. showed a
significantly increased concentration of IFN-γ throughout the
course of infection exclusively in both Tnf−/− and Tnfr1−/−
mice (Figure 2B). The expression level of IFN-γ mRNA in the
footpad lesions was initially comparable between infected wt and
Tnf−/− mice, but was significantly increased in Tnf−/− mice
after day 35 of infection (Figure 2C). IL-10 expression relative to
the housekeeping gene was also increased significantly at day 35
p. i. (Figure 2C). However, as demonstrated by flow cytometry,
the protein expression of IL-10 was substantially lower than of
IFN-γwhich points to an unexpectedly stable and even enhanced
Th1-type response in the absence of TNF (Figure 2C).
Expression Analysis of Transcription
Factors and Cytokines in Activated CD4+
T cells in L. major-Infected Wt and
Tnf−/− Mice
The polarization of T cell responses is strongly regulated by
the balance of a number of transcription factors such as
Tbx21 (Tbet) and Gata3 that regulate the expression of IFN-γ
and IL-4, respectively (Zheng and Flavell, 1997; Szabo et al.,
2000, 2002). To investigate a potential cause for the increased
IFN-γ expression in the absence of the TNF-TNFR1 signaling
pathway during the course of L. major infection, we isolated
populations of both activated (CD62L− CD44+) and naïve
CD4+ T cells (CD62L+ CD44−) from the spleens of Wt and
Tnf−/− mice at day 50 p. i. and analyzed the expression level
of several genes. The relative increase in Tbx21 expression in
activated T cells of both genotypes (Wt: mean = 134 [range
111.43–170.87]; Tnf−/−: mean = 34 [range 23.7–41.56]) was
in agreement with the observed increase in Ifn-γ expression
(497-fold upregulation in wt mice and 324-fold upregulation
in Tnf−/− mice) (Figure 3B). In contrast, the expression of
Gata3, which directs both IL-4 and IL-10 production (Zheng
and Flavell, 1997; Shoemaker et al., 2006), was only weakly
induced (1.6-fold) in activated wt CD4+ T cells and decreased
(1.42-fold) in activated Tnf−/− CD4+ T cells as compared to
the respective naive CD4+ T-cell populations (Figure 3A). This
was associated with a dramatic reduction of the IL-10 mRNA
expression (Figure 3B). Additionally, we analyzed the expression
of the transcription factor Rorγt (Rorc) which is characteristic for
the pro-inflammatory Th17 T cell subset (Yang et al., 2008). At
this late stage of infection it was up-regulated in activated CD4+
T cells of both wt (mean= 67.9-fold) and Tnf−/− (mean= 48.6-
fold) mice to a similar extent (Figure 3A), although expression
of IL-17A was generally low and barely detectable either by
real-time PCR (Figure 3B) or by intracellular cytokine staining
(Figure 2A).
Thus, only the Gata3 gene was expressed differently
between the genotypes and consequently IL-10 expression was
dramatically reduced in infected Tnf−/− mice. These data
further corroborate that mice lacking the TNF-TNFR1 signaling
pathway show an exaggerated Th1 response but nevertheless are
unable to resolve the infection.
Analysis of CD4+ T cell Activation During
Leishmaniasis
Both susceptible and resistant strains of mice were reported
to develop strong antigen-specific responses to epitopes of
the Leishmania homolog of receptors for activated C-kinase
antigen (LACK) with a predominant stimulation of Vα8 Vβ4-
positive T cells, whereas the Vβ5-expressing T cell population
did not expand (Launois et al., 2007). Therefore, we followed
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FIGURE 2 | TNF-TNFR1 signaling pathway deficiency results in elevated IFN-γ expression after L. major infection. (A) Cytokine expression in CD4+ T
cells from popliteal draining LNs of L. major infected Wt, Tnf−/− and BALB/c mice was analyzed. The use of the Tnf−/− mice constitutes the disruption of the
complete TNF-TNFR1 signaling pathway. Intracellular flow cytometry was used to determine the proportional expression of IFN-γ, IL-4, IL-17, and IL-10 in CD4+ T
cells at day 7 and 21 (and in the case of IL-10 also day 28) p. i. The experiment was performed two times independently and a representative staining is shown.
(B) The concentration of IFN-γ in the serum of L. major infected Wt, Tnf−/−, Tnfr1− /−, and Tnfr2−/− was determined. The data are presented as mean (±SEM;
n = 5–6 per genotype). Results are representative of at least 3 independent experiments. (C) The relative expression of IFN-γ and IL-10 in the footpad lesion of
infected Wt or Tnf−/− mice was compared to uninfected controls. Relative expression was calculated relative to β-actin as described (Meissner et al., 2003). The
data are presented as median (±SEM; n = 3–5 mice, representative of two independent experiments). The white bar represents Wt, the black bar Tnf−/− mice. The
non-parametric Mann–Whitney U-test was used for analysis of experiments displayed in (B,C) to test for statistical differences (∗p < 0.05 ∗∗p < 0.01).
the expansion of Vβ4 TCR+ CD4+ T cells and concurrently
analyzed the Vβ5.1/5.2 TCR+ CD4+ T cells (Launois et al.,
1997) in the draining pLNs of Wt, Tnf-, Tnfr1-, or Tnfr2-
deficient mice. The activation of these T cells was studied
using two classical activation markers of peripheral CD4+
T cells, CD62L and CD44 (Tough et al., 1996). Within the
draining LN isolated fromWt, Tnf−/−, Tnfr1−/−, and Tnfr2−/−
mice, a comparable proportion of T cells was Vβ4 TCR+
CD4+ (Figure 4A). However, the population of Vβ4 TCR+
CD4+ T cells from Tnf−/− and Tnfr1−/− mice contained a
significantly larger proportion of activated (CD62L− CD44+)
T cells (Figure 4A) and showed also an increase in the
absolute numbers of activated Vβ4 TCR+ CD4+ T cells within
the draining pLN (Figure 4B). Interestingly, Vβ5.1/5.2 TCR+
CD4+ T cells from Tnf−/− and Tnfr1−/− mice showed a
similar increase in activation as shown for Vβ4 TCR+ CD4+
T cells, pointing to a strong non-specific activation of the T
cell compartment in these genotypes (Figure 4B). In Wt as
well as Tnfr2-deficient mice neither Vβ4 TCR+ T cells nor
Vβ5 TCR+ T cells displayed significant activation at this time-
point of analysis. By day 50 p. i. the T cell compartment of
Tnf−/− mice had collapsed and both Vβ4 and Vβ5.1/5.2 TCR+
CD4+ T cell subsets were reduced within the pLN (data not
shown).
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FIGURE 3 | Expression of Tbx21 is unchanged while expression of Gata3 is reduced in activated Tnf-deficient CD4+ T cells. Naïve (CD62L+ CD44− ) as
well as activated (CD62L− CD44+ ) CD4+ T cells from Wt or Tnf−/− mice were isolated from the spleens of individual mice at day 50 after L. major infection.
Quantitative real time RT-PCR was performed to analyze the relative mRNA expression of transcription factors (A) and cytokines (B). The expression of the different
genes was normalized with the house keeping gene hypoxanthine guanine phosphoribosyl transferase (HPRT). Data are presented as median (±SEM) of the mRNA
expression ratio of activated vs. naive CD4+ T cells (n = 5–6 mice, one representative of two independent experiments is shown) (∗p < 0.05, ∗∗p < 0.01).
DISCUSSION
The TNF signaling pathways, especially the TNF-TNFR1
pathway, are essential in generating an inflammatory response
and mediating resistance to infection by intracellular pathogens
such as L. major (Wilhelm et al., 2001; Körner et al., 2010). In
the absence of the pro-inflammatory cytokine TNF the protection
against L. major is severely impaired resulting in a progressive
infection and eventually a fatal outcome. Interestingly, using
reciprocal bone marrow chimeras we could show that the ability
of hemopoietic cells to express TNF confers protection (Wilhelm
et al., 2001). The relatively subtle structural changes of lymphoid
organs in Tnf- and Tnfr1-gene deficient mice were not relevant
with regard to protection against L. major (Wilhelm et al., 2001).
In the present study we have analyzed the clinical course
of L. major infection in C57BL/6 mouse strains deficient for
TNF, soluble TNF (memTnf/), TNFR1 or TNFR2 and could
show that the outcome was fatal in the absence of TNF and
TNFR1. A deficiency of soluble TNF did not impair the healing
phenotype associated with the C57BL/6 background as long as
the membrane-bound cytokine was still expressed. This is in
agreement with earlier studies that showed that transmembrane
TNF expressed on CD4+ T cells was sufficient to induce a
protective anti-Leishmania immune response (Birkland et al.,
1992; Allenbach et al., 2008). A Tnfr2-deficiency resulted in the
development of large skin lesions, which, however, ultimately was
resolved. The fatal outcome observed in L. major infected Tnf- or
Tnfr1-deficient mice occurred despite a seemingly intact adaptive
immune response and an over-expression of IFN-γ.
Our results describing a fatal course of L. major infection in
TNF−/− (Wilhelm et al., 2001) contrast with two other studies
published in experimental cutaneous leishmaniasis, which either
used anti-TNF antibodies in C3H/HeN mice (Titus et al., 1989)
or a Tnf−/− strain on a different mouse background (Chakour
et al., 2003). In both cases an aggravated clincial course of
infection was observed, but the mice resolved the lesions and
survived. Similarly, our findings on the contribution of TNFR1
or TNFR2 to the protective response to L. major also differ
from several earlier reports. Vieira et al. (1996) used a Tnfr1−/−
strain generated on a 129Sv background and showed that these
mice survived the infection and eliminated the parasites but
did not completely resolve the skin swelling and pathology.
Infection of Tnfr2−/− mice on a mixed 129Sv × C57BL/6
background showed that this receptor was dispensable for the
control of L. major (Nashleanas et al., 1998) and, finally,
an infection of a Tnfr1/2 double-deficient 129Sv × C57BL/6
mouse followed the Tnfr1−/− phenotype (Nashleanas et al.,
1998). In the present study, we compared memTnf/, Tnf−/−,
Tnfr1−/−, and Tnfr2−/− mice on an identical C57BL/6 genetic
background using the L. major parasite strain BNI to account
for differences caused by the genetic variability of the infected
mouse strain and the parasite strain used (Ritter et al., 2004). In
our experiments the previously observed phenotypes could not
be replicated with the exception of the resistance of memTnf/
to the infection. Both Tnfr1−/− and Tnfr2−/− mice displayed
a lesion development comparable to Tnf−/− mice suggesting
overlapping roles for the two receptors in the pathogenesis of
leishmaniasis. Interestingly, Tnfr2−/− mice ultimately survived,
whereas both Tnf−/− and Tnfr1−/− mice developed signs of
severe systemic disease and succumbed to the infection.
Experimental cutaneous leishmaniasis in genetically inbred
mice was the first model which showed a mouse strain-
dependent polarization of IL-4 and IFN-γ production by CD4+
T cells correlating with either disease susceptibility or resistance
(Heinzel et al., 1989) and therefore formed the basis of the
Th1 and Th2 paradigm (Mosmann and Coffman, 1989). In our
experiments, the expression of IL-10 paralleled the expression of
IL-4. Additionally, we detected a small percentage of both IFN-
γ/IL-10 and IFN-γ/IL-4 double positive T cells at day 7 p. i. which
disappeared soon after. These cells could be part of a regulatory
subpopulation or represent random heterogeneity during T cell
differentiation at the beginning of the antigen-specific immune
response (Morris et al., 1992). The major argument for a central
role of IFN-γ in resistance to L. major infection has been its
polarizing influence on CD4+ T cell differentiation (Heinzel
et al., 1989; Laouar et al., 2005) and its activating effect on
macrophages with the induction of leishmanicidal NO in vitro
(Liew et al., 1990) and in vivo (Stenger et al., 1994, 1996;
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FIGURE 4 | Expansion and activation of Vβ4 and Vβ5.1/5.2 TCR repertoire occurs in the absence of TNF or TNFR1 but not TNFR2. Wt mice or mice
lacking TNF, TNFR1, or TNFR2 were infected with 3 × 106 L. major promastigotes and draining pLN were harvested at day 21 p. i. (A) Tnf- and Tnfr1-deficient mice
showed increased activation of CD4+ T cells expressing either Vβ4 or Vβ5.1/5.2 TCR chains. One of two representative experiments is shown. (B) Increased
activation was correlated with increased absolute numbers of both Vβ4 or 5 restricted activated (CD62L− CD44+ ) CD4+ T cells in the draining pLN by a comparable
size of the organs. Statistical comparisons were performed using a Kruskal–Wallis Test with Dunns correction; n = 5–6 per genotyope ∗p ≤ 0.05, ∗∗p ≤ 0.01,
∗∗∗p < 0.001.
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Diefenbach et al., 1998). This has been tested by administration
of anti-IFN-γ mAbs to C3H/HeN mice which prevented the
development of natural resistance (Belosevic et al., 1989; Scott,
1991). However, several studies have called into question
this fundamental role for IFN-γ in the sequence of events
resulting in protection. First, while the administration of anti-
IL-4 mAb to susceptible BALB/c mice prevented progressive
uncontrolled infection of L. major (Sadick et al., 1990) and
was paralleled by an up-regulation of IFN-γ production, the
concurrent neutralization of this elevated IFN-γ did not abrogate
or change the resistance phenotype. Second, mice congenic
for known resistance loci (Lmr1, Lmr2, Lmr3) derived from
either resistant C57BL/6 or susceptible BALB/c mice did not
display the expected susceptible/resistant phenotype despite
expressing either IL-4 or IFN-γ suggesting that the IFN-γ/IL-
4 cytokine profile alone is not a sufficient determinant of
disease resistance (Elso et al., 2004a,b; Sakthianandeswaren et al.,
2010). Resistant C57BL/6 mice carrying a BALB/c congenic
region for lmr1 displayed increased susceptibility while the
reciprocal congenic strain (BALB/c) containing the C57BL/6
allele showed an intermediate phenotype (Elso et al., 2004a).
Third, following infection with a L. major strain isolated
from patient with chronic cutaneous leishmaniasis a non-
healing course of disease was observed in C57BL/6 mice despite
efficient Th1 polarization (Anderson et al., 2005). Fourth, in
our present study we showed that mice deficient for TNF or
TNFR1 overexpressed IFN-γ and displayed intact, relatively
strong expression of iNOS in the draining LN (Wilhelm
et al., 2001), yet, counterintuitively, developed progressive,
and ultimately fatal leishmaniasis. While a synergy between
IFN-γ and pro-inflammatory mediators (e.g., TNF) based on
cooperative signaling through STAT1, IRF-1 and NFκB (Drapier
et al., 1988; Ohmori et al., 1997; Saura et al., 1999; Schroder
et al., 2004; Farlik et al., 2010) has been described in vitro
for the production of NO by macrophages (Bogdan et al.,
1990; Green et al., 1990; Ding et al., 1998), there appears
to be a high level of redundancy in vivo. Nevertheless,
despite intact induction of iNOS which is associated with
parasite clearance (Stenger et al., 1994, 1996; Diefenbach
et al., 1998; Blos et al., 2003), Tnf−/− mice still failed to
control parasite growth and dissemination (Wilhelm et al.,
2001).
Taken together, the lack of resistance to L. major infection
in Tnf−/− and Tnfr1−/− mice despite an increased production
of IFN-γ points to a central role for TNF/TNFR1 signaling
in linking innate leishmanicidal effector mechanisms with the
adaptive immune response. Since TNF has been shown to
modulate the expansion of regulatory T cell networks (Chen
et al., 2007), the absence of TNF signaling may modify the
local immune response in a way that it becomes refractory
to the activity of IFN-γ and iNOS and therefore unable
to prevent progressive infection. In addition, the sustained
presence of large amounts of systemic IFN-γ throughout the
course of leishmaniasis in Tnf-negative mice may be the
consequence of ongoing infection and parasite dissemination.
Instead of promoting protection by activating macrophages the
overproduction of IFN-γ could result in immunopathology that
contributes to a fatal outcome in response to infection with
L. major.
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